Robeco QI Global Developed Conservative Equities

161,41
-0,59%
06/12/2022
Riesgo
5/7
ISIN
LU1274519823
Patrimonio
242,1M€
Rentabilidad YTD
0,19%

Estrategia de inversión

The aim of the Sub-fund is to provide long term capital growth by taking exposure of at least two-thirds of its total assets to equities of companies that mainly operate in mature economies (developed markets) all over the world. The Sub-fund will focus on investing in equities that show lower expected volatility than average global equity. Conservative stands for the focus on equity with lower expected volatility.

Comisiones

Defer Load
0.00%
Front Load
5.00%
Management Fee
0.80%
On Going Charge
1.01%
Redemption Fee
0.00%
Total Expense Ratio
1.02%

Otras clases

Nombre ISIN Comisión
Robeco QI Global Developed Conservative Equities I € LU1274520086 0,45 %
Robeco QI Global Developed Conservative Equities D € LU1274519823 0,80 %

Rentabilidad por períodos

Período
Acumulada
Anualizada
Año actual
0,19% -
30 días
-1,50% -
6 meses
2,58% -
12 meses
3,25% -
2 años
29,75% 13,91%
3 años
15,59% 4,95%
5 años
33,46% 5,94%

Rentabilidad por trimestres

Año T1 T2 T3 T4
2015 - - - - 8,27%
2016 7,30% -1,16% 5,27% -1,35% 4,53%
2017 3,96% 5,21% -3,07% -0,47% 2,42%
2018 -6,24% -4,70% 4,47% 4,16% -9,60%
2019 23,60% 13,34% 1,91% 6,95% 0,06%
2020 -9,85% -19,26% 8,08% 0,19% 3,12%
2021 28,19% 9,02% 4,26% 1,37% 11,26%
2022 - -0,49% -4,55% 0,29% -

Rentabilidad mensual

Rentabilidad de los últimos 12 meses

Cartera

#
Posición
Peso
Valor
1
Apple Inc
2,63%
6.486.716€
2
Bristol-Myers Squibb Co
2,12%
5.223.972€
3
Exxon Mobil Corp
2,06%
5.081.889€
4
Merck & Co Inc
2,02%
4.961.652€
5
Amgen Inc
2,00%
4.932.414€
6
Chevron Corp
1,96%
4.819.607€
7
Johnson & Johnson
1,68%
4.134.373€
8
Automatic Data Processing Inc
1,61%
3.962.672€
9
AbbVie Inc
1,59%
3.924.952€
10
Royal Bank of Canada
1,58%
3.891.908€

Principales 10 posiciones en cartera

Categoría

Top Robeco QI Global Developed Conservative Equities frente a su categoría

Documentos

Documento
Última actualización
Prospectus
09/11/2022
Factsheet
26/11/2022
Factsheet Institutional
26/11/2022
SemiannualReport
24/11/2022
Key Investor Information Document (KIID)
20/02/2022
AnnualReport
24/11/2022
Rulebook
09/11/2022

Divisas

Materias primas

Volver arriba